Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
869901-69-9
|
| gptkbp:developedBy |
gptkb:Pfizer
|
| gptkbp:hasApplication |
cancer research
anti-inflammatory research |
| gptkbp:hasInChIKey |
QJQYQKZQKZQKQK-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C18H12F3N5O
|
| gptkbp:hasSMILES |
C1CN(C2=NC=NC3=C2C=CC(=C3N1)C4=CC=NC=C4)C(F)(F)F
|
| gptkbp:heldBy |
p38 MAP kinase inhibitor
|
| https://www.w3.org/2000/01/rdf-schema#label |
PF-3644022
|
| gptkbp:IUPACName |
2-(1H-indazol-4-yl)-6-(4-pyridinyl)-8-(trifluoromethyl)-7,8-dihydro-6H-pyrido[2,3-d]pyrimidin-7-one
|
| gptkbp:mechanismOfAction |
inhibits p38α MAP kinase
|
| gptkbp:molecularWeight |
371.32 g/mol
|
| gptkbp:PubChem_CID |
11524142
CHEMBL180037 |
| gptkbp:bfsParent |
gptkb:MAPKAPK2
|
| gptkbp:bfsLayer |
7
|